Emerging Tools and Technologies for Microbiome‐Aware Drug Development
Clinical Pharmacology & Therapeutics · 2025-12 · 118 (6) · 1265-1268
DOI: 10.1002/cpt.70026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 11.08.2025. Verfasst von Henry J Haiser und 1 weiteren Autor:innen. Beteiligte Einrichtung: Corundum Systems Biology, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drug Development, Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Pharmacomicrobiomics explores the role of the gut microbiota in pharmacokinetics and pharmacodynamics, paving the way for new biomarkers and intervention strategies to reduce interindividual variability in drug response. Emerging mechanistic insights and tools enable microbiome‐aware approaches as a promising new facet of personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Corundum Systems Biology, Boston, Massachusetts, USA.
- Independent Researcher, London, UK.
Zitieren
APA
Haiser, H. J., & de Gruijl, D. (2025). Emerging Tools and Technologies for Microbiome‐Aware Drug Development. Clinical Pharmacology & Therapeutics, 118(6), 1265-1268. https://doi.org/10.1002/cpt.70026
Vancouver
Haiser HJ, de Gruijl D. Emerging Tools and Technologies for Microbiome‐Aware Drug Development. Clinical Pharmacology & Therapeutics. 2025;118(6):1265-1268. doi:10.1002/cpt.70026
BibTeX
@article{Haiser2025,
author = {Haiser, Henry J and de Gruijl, David},
title = {Emerging Tools and Technologies for Microbiome‐Aware Drug Development},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
volume = {118},
number = {6},
pages = {1265--1268},
doi = {10.1002/cpt.70026}
}
EUVIMED